1 / 40

Insulin Therapy 101a

Patient, 2004. Mrs. Alegria is a 46 year old woman who was diagnosed with type 2 DM about 6 years ago. She has a history of GDM (her daughter is now 8 years old); both her sisters have DM2. She works as a home health aide.She is on metformin 1000 mg bid, and on glipizide 10 mg every morning.H

azize
Télécharger la présentation

Insulin Therapy 101a

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Insulin Therapy 101a T. Villela, MD Family Practice Residency Program San Francisco General Hospital October 2004

    2. Patient, 2004 Mrs. Alegria is a 46 year old woman who was diagnosed with type 2 DM about 6 years ago. She has a history of GDM (her daughter is now 8 years old); both her sisters have DM2. She works as a home health aide. She is on metformin 1000 mg bid, and on glipizide 10 mg every morning. Her A1C, which was 7% in 2002, has been climbing steadily and is now 9.6%.

    3. Patient, 2004, continued Adherence? Adequate doses of medications, taken at correct times? Changes in activity, weight, or diet? OR Natural progression of disease?

    4. Progressive decline in beta-cell function/insulin secretion in DM2 At diagnosis, B-cell function is approx 50%, within six years, it hovers around 20%. At diagnosis, B-cell function is approx 50%, within six years, it hovers around 20%.

    5. Progressive decline in beta-cell function/insulin secretion in DM2: can it be slowed? Increasing failure of monotherapy at 9 years post dx Within that time, improved control associated with metformin/insulin or metformin/SU Success wanes at about 9 years

    6. Patient, 2004, continued Options Increase physical activity/Nutrition consult Glitazone Expensive MUST monitor ALT regularly Weight gain/edema Increase Glipizide to 20 mg q AM Not much extra benefit Add bedtime insulin (augmentation therapy, B.I.D.S.)

    7. Patient, 2004, continued Her weight is 90 Kg She eats three meals/day She has the following record of her SMG

    8. Goals for Glycemic Control (ADA)

More Related